Home › Trial NCT03238885
Predicting Pathological Complete Response of Rectal Cancer With Magnetic Resonance(MR) Radiomics
- Trial IDNCT03238885
- StatusCompleted
- PhaseN/A
- Study typeObservational
- SponsorSun Ying-Shi
- Enrollment538
- Start date2013-03-01
- ConditionsLocally Advanced Rectal Cancer
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.